Business

Global Viral Vector and Plasmid DNA Manufacturing Market : Opportunity and Industry Revenue Analysis | Oxford Biomedica PLC, Thermo Fisher Scientific Inc., Gilead Company, etc.

Introduction:

Viral vectors and plasmid DNA are used in gene therapy. It is used to treat various diseases, such as Parkinson’s disease, Alzheimer’s disease, cancer, and other diseases. Gene therapies and other therapies that need genetic modification include the introduction of therapeutic DNA/gene in the patient’s cell or body. This process is proficient by the use of viral vectors. In the past few years, different non-viral and viral vectors have been standardized and developed for the treatment purpose. Besides this, the viral vectors and plasmid DNAs are anticipated to decrease the repetitive administration of medications.

Drivers and Restraints:

The increasing number of cancer patients drives the growth of the global viral vector and plasmid DNA manufacturing market globally. Viral vectors and plasmid DNA are used to treat diseases such as cancer and various other diseases globally. For instance, according to the WHO (World Health Organization), in 2018, globally, cancer is the second most leading cause of death, an estimated 9.6 million deaths. Additionally, the technological advancement in the production of a viral vector to take care of patients which are another driving factor for the growth of the target market. Furthermore, the rise in the number of clinical trials of viral vector and plasmid DNA for better treatment is the fueling factor for the growth of the global market. Moreover, there is the rapid development of clinical trial phases due to growing numbers of candidates for the use of viral vector and plasmid DNA which is the boosting factor for the growth of the target market. However, the gene therapies are expensive treatment which is the major restraining factor for the growth of the target market.

Request Sample Copy: https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/3817

  1. Global Viral Vector and Plasmid DNA Manufacturing  Market, By Product Type, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Plasmid DNA
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Viral Vectors
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Non- viral Vectors
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  2. Global Viral Vector and Plasmid DNA Manufacturing  Market, By Application, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Cancer
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Inherited Disorder
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Infectious Diseases
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Other Applications
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030

Company Profile:

  • Uniqure NV *
        • Company Overview
        • Product Type Portfolio
        • Key Highlights
        • Financial Performance
  • Cell and Gene Therapy Catapult
  • FinVector Vision Therapies
  • Fujifilm Holdings Corporation (Fujifilm Diosynth Biotechnologies)
  • MassBiologics
  • SIRION Biotech
  • Cobro Biologics
  • Merck KGaA
  • Oxford Biomedica PLC
  • Thermo Fisher Scientific Inc.
  • Gilead Company

Contact Us:

Mr. Alex (Sales Manager)
Prophecy Market Insights
Phone: +1 860 531 2701 / +91 777 504 9802
Email: [email protected]

Back to top button